Impact of Healthcare Expenditures on Healthcare Outcomes in the Middle East and North Africa (MENA) Region: A Cross-Country Comparison, 1995-2015
- PMID: 33614570
- PMCID: PMC7890180
- DOI: 10.3389/fpubh.2020.624962
Impact of Healthcare Expenditures on Healthcare Outcomes in the Middle East and North Africa (MENA) Region: A Cross-Country Comparison, 1995-2015
Abstract
The association between healthcare expenditures and outcomes, mainly mortality and life expectancy, is complex. The real explanation for this association is not clear, especially in the Middle East and North Africa (MENA) region. This study assesses the impact of health expenditures on improving healthcare systems and health status and finds a relationship between health expenditures and health outcomes across different region. Annual time series data on healthcare spending and outcomes from 1995 to 2015 were used for MENA region in comparison to developed and developing countries. Health expenditure was adjusted by the consumer price index equation to the 2015 US dollar eliminate the impact of inflation on our results. For many countries, spending on healthcare continues to rise, Among MENA countries, we found that the United Arab Emirates and Kuwait spent more per capita on health, $1,711 and $1,420, respectively, than any other countries in the region. Although this study demonstrated a relationship between total healthcare expenditure and outcomes, some countries spend more on healthcare but have shorter life expectancy. In most countries, efficient and effective utilization of healthcare resources is the key strategy for improving health outcomes in any country. The lack of a positive correlation between healthcare spending and life expectancy may indicate that health resources are not allocated effectively. In those cases, increasing health spending does not guarantee that there is any kind of improvement in healthcare.
Keywords: Middle East-North Africa; cross-nation comparison; healthcare expenditures trend; healthcare resources; life expectancy.
Copyright © 2021 Balkhi, Alshayban and Alotaibi.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures


Similar articles
-
The Profile of Non-Communicable Disease (NCD) research in the Middle East and North Africa (MENA) region: Analyzing the NCD burden, research outputs and international research collaboration.PLoS One. 2020 Apr 27;15(4):e0232077. doi: 10.1371/journal.pone.0232077. eCollection 2020. PLoS One. 2020. PMID: 32339197 Free PMC article.
-
Measuring Efficiency of Health Systems of the Middle East and North Africa (MENA) Region Using Stochastic Frontier Analysis.Appl Health Econ Health Policy. 2016 Jun;14(3):337-47. doi: 10.1007/s40258-016-0230-9. Appl Health Econ Health Policy. 2016. PMID: 26914550
-
SARS-CoV-2 Surveillance in the Middle East and North Africa: Longitudinal Trend Analysis.J Med Internet Res. 2021 Jan 15;23(1):e25830. doi: 10.2196/25830. J Med Internet Res. 2021. PMID: 33302252 Free PMC article.
-
Multiple sclerosis: economic burden, therapeutic advances, and future forecasts in the Middle East and North Africa region.Expert Rev Pharmacoecon Outcomes Res. 2024 Oct;24(8):873-882. doi: 10.1080/14737167.2024.2364832. Epub 2024 Jun 7. Expert Rev Pharmacoecon Outcomes Res. 2024. PMID: 38832693 Review.
-
Disease-Related Costs Published in The Middle East and North Africa Region: Systematic Review and Analysis of Transferability.Pharmacoeconomics. 2022 Jun;40(6):587-599. doi: 10.1007/s40273-022-01146-6. Epub 2022 May 17. Pharmacoeconomics. 2022. PMID: 35578009 Free PMC article.
Cited by
-
The association between health expenditure, institutions, and economic growth in MENA countries.Health Promot Perspect. 2022 May 29;12(1):92-100. doi: 10.34172/hpp.2022.12. eCollection 2022. Health Promot Perspect. 2022. PMID: 35854854 Free PMC article.
-
Spatiotemporal patterns of healthy life expectancy and the effects of health financing in West African countries, 1995-2019: A Spatial Panel Modelling Study.J Glob Health. 2023 Oct 20;13:04123. doi: 10.7189/jogh.13.04123. J Glob Health. 2023. PMID: 37861131 Free PMC article.
-
Government health expenditures and health outcome nexus: a study on OECD countries.Front Public Health. 2023 Apr 17;11:1123759. doi: 10.3389/fpubh.2023.1123759. eCollection 2023. Front Public Health. 2023. PMID: 37139401 Free PMC article.
-
Analysis of Regional Differences, Dynamic Evolution, and Influencing Factors of Medical Service Levels in Guangzhou Under the Health China Strategy.Risk Manag Healthc Policy. 2024 Nov 14;17:2811-2828. doi: 10.2147/RMHP.S479911. eCollection 2024. Risk Manag Healthc Policy. 2024. PMID: 39558909 Free PMC article.
-
Facilitators and barriers to generic and biosimilar medications in the Middle East and North Africa: insights from physicians and pharmacists-a systematic review.Eur J Clin Pharmacol. 2025 May;81(5):647-665. doi: 10.1007/s00228-025-03819-5. Epub 2025 Mar 14. Eur J Clin Pharmacol. 2025. PMID: 40085198 Free PMC article.
References
-
- Jabaa E, Balana C, Robua I. The relationship between life expectancy at birth and health expenditures estimated by a cross-country and time-series analysis. Procedia Econ Finance. (2014) 108–14. 10.1016/S2212-5671(14)00454-7 - DOI
-
- Rascati K. Essentials of Pharmacoeconomics. 2nd edition Philadelphia, PA: Wolters Kluwer; (2014).
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials